Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PraBotulinum toxin A injection for gastric emptying after pylorus-preserving gastrectomy (BIGEPPG)
KCT0004077Phase 3Not yet recruiting
- Sponsor
- Daewoong Pharmaceutical
- Start
- Jul 2019
- Modality
- Bacterial Toxin Conjugates → Immunotoxins → Antibody Conjugates → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of prabotulinumtoxinA in gastric cancer (GC) (2 arms), sponsored by Daewoong Pharmaceutical. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
prabotulinumtoxinA
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on KCT0004077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004077.